Skip to main content
. 2017 Jul 26;5(5):569–577. doi: 10.3889/oamjms.2017.058

Figure 5.

Figure 5

Expression of EGFR (brown colour) in the Gastric Corpus of Control (A), ASA Only (B), MP Treated (C, D, E) and OMZ Treated (F) Groups on Day 21. Note the EGFR immunoreactivity in the control and treatment groups. X400